Research continues to accelerate for myelodysplastic syndromes (MDS), giving hope to patients and their loved ones. In this episode, Dr. William Shomali of Stanford University dives into cutting-edge treatments for both low and high-risk MDS. Learn about the innovative therapies that are enhancing quality of life and explore the promising strides towards curative treatments. Don’t miss this inspiring conversation filled with valuable insights and hope for a brighter future.  

Podcast: Play in new window | Download

Subscribe: Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

• Myelodysplastic syndromes (MDS)
• Acute myeloid leukemia (AML)
• IPSS-Molecular (IPSS-M) risk stratification
• Bone marrow transplantation
• Iron chelation
• CAR T-cell Therapy
• Bispecific Antibodies
• Clinical Trial Support Center

Additional LLS Support Resources: 

• Information Specialists 
• Free Nutrition Consultations
• Financial support
• Free telephone/web patient programs 
• Free booklets 
• Young Adult Resources
• Online chats 
• Support groups 
• Caregiver support 
• Caregiver Workbook
• Advocacy and Public Policy
• Survivorship Workbook
• LLS Community 
• Mental Health Resources

Support for this episode provided by Geron Corporation and Taiho Oncology, Inc.